Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of Tisporin vs Restasis eye drops in moderate to severe dry eye disease
KCT0001229Phase 3Completed
- Sponsor
- Hanlim Pharm
- Start
- Dec 2013
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of Tisporin, cyclosporine in dry eye syndrome (DED), sponsored by Hanlim Pharm. Started Dec 2013; status: completed.
02
Drugs
Tisporincyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on KCT0001229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001229.